CN103664681A - Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide - Google Patents

Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide Download PDF

Info

Publication number
CN103664681A
CN103664681A CN201210345222.8A CN201210345222A CN103664681A CN 103664681 A CN103664681 A CN 103664681A CN 201210345222 A CN201210345222 A CN 201210345222A CN 103664681 A CN103664681 A CN 103664681A
Authority
CN
China
Prior art keywords
preparation
phenyl
consumption
dimethoxy
trimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210345222.8A
Other languages
Chinese (zh)
Inventor
杨晓丽
韦丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210345222.8A priority Critical patent/CN103664681A/en
Publication of CN103664681A publication Critical patent/CN103664681A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide. The preparation method comprises the following steps: (1) adding 3,4,5-dimethoxy-1-aminoacetyl phenyl hydrobromide, 3,4,5-trimethoxy phenylacetate, DMAP (dimethylaminopyridine) and anhydrous dichloromethane in a reaction flask, cooling to 0 DEG.C, adding EDCI.HCl under the nitrogen protection, stirring to react for 30 minutes, and then warming to room temperature, and continuously stirring to react for 24 hours; (2) orderly washing by using 2.0mol/L hydrochloric acid, a saturated sodium bicarbonate solution and a saturated saline solution, drying by using anhydrous sodium sulfate, removing the solvent through reduced pressure evaporation, and recrystallizing residue by using dichloromethane-ethyl acetate to obtain the N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide. The preparation method has the advantages that the method is simple and convenient, and the yield can achieve 76%.

Description

N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl] preparation method of-2-(3,4,5-trimethoxyphenyl) ethanamide
Technical field
The invention belongs to organic chemical synthesis technical field, be specifically related to a kind of N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl] preparation method of-2-(3,4,5-trimethoxyphenyl) ethanamide.
Background technology
Combretastatin (Combretastatins) is the natural product with anticancer activity that separation obtains from South Africa shrub (Combretum caffrum), it is by suppressing tubulin polymerization, optionally stop blood to flow to tumour, cause death of neoplastic cells, thereby reach anticancer object.In this class natural product, the activity of Combretastatin A4 (CA-4) is the highest, and kinds of tumors is had to strong restraining effect.Due to the poorly water-soluble of CA-4, bioavailability is low, therefore changes its phosphorylated into water miscible phosphate disodium salt predrug (CA-4P), and its anti-tumor in vivo activity improves greatly.CA4P has entered the clinical study stage three phases.But CA-4 has the shortcoming for the E-configuration without antitumour activity from Z-configurational isomerization.For fixing Z-configuration, for bibliographical information, five yuan of fragrant heterocycles such as imidazoles, oxazole, thiazole, pyrazoles, triazole and furazan replace the ethylene linkage in CA-4 molecules in recent years.In these CA-4 analogues, the Anticancer Activity in vitro of some compounds and CA-4 are quite even higher than CA-4.The ethylene linkage that replaces CA-4 with suitable rigidity alicyclic ring, also can reach the fixedly object of Z-configuration.The ring butyramide of the use such as Niamh alicyclic ring replaces the IC of the synthetic CA-4 analogue of the ethylene linkage of CA-4 to MCF-7 tumour cell 50value reaches 10nmolL -1level, the derivative after the ethylene linkage of the maleinamide replacement CA-4 of the use such as Dannhardt alicyclic ring is as tumour cell microtubule polymerization inhibitor, IC 50value also reaches nmole level level.But less with the CA-4 analogue bibliographical information of unit centered by alicyclic ring.
In order to study rigidity alicyclic ring, replace on CA-4 analogue that ethylene linkage builds and aromatic ring substituting group on bioactive impact, applicant has synthesized the CA-4 analogue of unit centered by a series of new alicyclic rings, 3,4-diaryl pyrrole-2,5-diketone and 3,4-diaryl pyrrole-2-ketone.Therefore, need a kind of N-[2-of special design (3,4-Dimethoxyphenyl)-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl) ethanamide.In actual fabrication process, change bromide into primary amine, conventional method is Gabriel synthesis method.But in Gabriel reaction, need just can obtain primary amine with hydrazine hydrate hydrazinolysis, and carbonyl in reactant is easy and hydrazine condensation causes lower yield.
Summary of the invention
For solving the problems of the technologies described above, the object of the present invention is to provide a kind of N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl) preparation method of ethanamide, the method not only method for making is easy, and productive rate is higher.
The present invention solves the problems of the technologies described above taked technical scheme: a kind of N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl) preparation method of ethanamide, it is characterized in that comprising the steps: that (1) adds 3 in reaction flask, 4-dimethoxy-1-glycyl benzene hydrobromate, 3,4,5-trimethoxy toluylic acid, DMAP and anhydrous methylene chloride, be cooled to 0 ℃, under nitrogen protection, add EDCIHCl, after stirring reaction 30min, rise to room temperature, continue stirring reaction 24h; (2) use successively 2.0mol/L hydrochloric acid, saturated sodium bicarbonate solution, saturated common salt water washing, anhydrous sodium sulfate drying, pressure reducing and steaming solvent, methylene dichloride-re-crystallizing in ethyl acetate for residue, obtain N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl) ethanamide.
As preferably; described 3; 4-dimethoxy-1-glycyl benzene hydrobromate consumption is 0.5g, described 3; 4; 5-trimethoxy toluylic acid consumption is that 0.41g, described DMAP consumption are that 0.55g, described anhydrous methylene chloride consumption are 35mL; described EDCIHCl consumption is 0.38g, and described hydrochloric acid, saturated sodium bicarbonate solution, saturated common salt water consumption are 50mL.
Technique of the present invention is simple, and easily, productive rate is higher in preparation.Preparation method's of the present invention N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl] productive rate of-2-(3,4,5-trimethoxyphenyl) ethanamide can reach more than 76%.
Embodiment
Below in conjunction with embodiment, to of the present invention, be further elaborated.
Embodiment 1: in reaction flask, add 0.5g 3; 4-dimethoxy-1-glycyl benzene hydrobromate, 0.41G 3,4,5-trimethoxy toluylic acid, 0.55g DMAP and 35mL anhydrous methylene chloride; be cooled to 0 ℃, under nitrogen protection, add 0.38gEDCIHCl.After stirring reaction 30min, rise to room temperature, continue stirring reaction 24h.Then use successively 50mL 2.0mol/L hydrochloric acid, 50mL saturated sodium bicarbonate solution, the water washing of 50mL saturated common salt, anhydrous sodium sulfate drying.Pressure reducing and steaming solvent, residue obtains compound N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl]-2-(3 of 0.55g (1.36mmol) by methylene dichloride-re-crystallizing in ethyl acetate, 4,5-trimethoxyphenyl) ethanamide, white solid, productive rate 76%.
Though it is pointed out that above-described embodiment is to the present invention's detailed text description of contrasting, these text descriptions are the simple description to mentality of designing of the present invention just, rather than the restriction to thinking of the present invention.Any combination, increase or modification that is no more than mentality of designing of the present invention, all falls within the scope of protection of the present invention.

Claims (2)

1. a N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl] preparation method of-2-(3,4,5-trimethoxyphenyl) ethanamide, it is characterized in that comprising the steps: that (1) adds 3 in reaction flask, 4-dimethoxy-1-glycyl benzene hydrobromate, 3,4,5-trimethoxy toluylic acid, DMAP and anhydrous methylene chloride, be cooled to 0 ℃, under nitrogen protection, add EDCIHCl, after stirring reaction 30min, rise to room temperature, continue stirring reaction 24h; (2) use successively 2.0mol/L hydrochloric acid, saturated sodium bicarbonate solution, saturated common salt water washing, anhydrous sodium sulfate drying, pressure reducing and steaming solvent, methylene dichloride-re-crystallizing in ethyl acetate for residue, obtain N-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl]-2-(3,4,5-trimethoxyphenyl) ethanamide.
2. N-[2-(3 according to claim 1; 4-Dimethoxyphenyl)-2-oxoethyl]-2-(3; 4; 5-trimethoxyphenyl) preparation method of ethanamide; it is characterized in that: described 3; 4-dimethoxy-1-glycyl benzene hydrobromate consumption is 0.5g, described 3; 4; 5-trimethoxy toluylic acid consumption is that 0.41g, described DMAP consumption are that 0.55g, described anhydrous methylene chloride consumption are 35mL; described EDCIHCl consumption is 0.38g, and described hydrochloric acid, saturated sodium bicarbonate solution, saturated common salt water consumption are 50mL.
CN201210345222.8A 2012-09-18 2012-09-18 Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide Pending CN103664681A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210345222.8A CN103664681A (en) 2012-09-18 2012-09-18 Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210345222.8A CN103664681A (en) 2012-09-18 2012-09-18 Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide

Publications (1)

Publication Number Publication Date
CN103664681A true CN103664681A (en) 2014-03-26

Family

ID=50303569

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210345222.8A Pending CN103664681A (en) 2012-09-18 2012-09-18 Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide

Country Status (1)

Country Link
CN (1) CN103664681A (en)

Similar Documents

Publication Publication Date Title
ES2424362T3 (en) Nebivolol preparation process
ES2861931T3 (en) New Epicatechin Analogs and Related Polyphenols
CN106349310B (en) The preparation method of emamectin-benzoate
CN104557863A (en) Novel nicotinamide ribose phosphate transferase inhibitor as well as synthetic method and application thereof
CN103145583B (en) Raceme alkannin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative and preparation and application thereof
CN110143941A (en) A kind of synthetic method of Barrow Sa Weimabo ester intermediate
La et al. A fast and practical synthesis of tert-butyl esters from 2-tert-butoxypyridine using boron trifluoride· diethyl etherate under mild conditions
CN103664681A (en) Preparation method of N-[2-(3,4-dimethoxy phenyl)-2-oxo-ethyl]-2-(3,4,5-trimethoxy phenyl) acetamide
FR2459239A1 (en) NOVEL AMINO DERIVATIVES OF BENZOTHIAZOLE, PROCESS FOR PREPARING THEM AND THEIR THERAPEUTIC APPLICATION
CN101235020B (en) Substituted cinnamamide derivatives and application of the same as nerve protecting agent
Wang et al. Synthesis of a novel poly (ethylene glycol) grafted triethylamine functionalized dicationic ionic liquid and its application in one-pot synthesis of 2-amino-2-chromene derivatives in water
Endo et al. Molecular construction based on icosahedral carboranes and aromatic N, N′-dimethylurea groups. Aromatic layered molecules and a transition metal complex
CN101921195A (en) Simple method for synthesizing intermediate of retigabine
CN103664664A (en) Preparation method of 3-fluoro-4-methoxy-1-aminoacetylphneyl hydrobromide
CN104876916A (en) Preparation method of difenoconazole
CN103664731A (en) Preparation method of 3-(3,4-dimethoxy phenyl)-4-(3,4,5-trimethoxy phenyl)-1H-pyrrole-2,5-dione
CN107382822A (en) A kind of preparation method and product of carbazolyl-containing chalcone
CN103664663A (en) Preparation method of 3,4-dimethoxy-1-aminoacetylphenyl hydrobromide
JPH01305078A (en) Novel heteroarotinoide derivative
CN102627626A (en) Preparation method of 2, 3-thiophenedicarboxaldehyde
CN103553985B (en) 4-methoxy-N,N-bisubstituted phenyl-1,3-benzene bisulfonamide compound and application thereof
CN106673967B (en) Preparation method of 4- (2-methallyl) -1, 2-benzenediol
JP2018009100A5 (en)
CN100360508C (en) Imidazole-2-ketone compound and its preparing method and use
CN103755664A (en) 4-arylthia(selena)zole compounds and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140326